Victory Capital Management Inc. lifted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 296.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 231,059 shares of the company's stock after acquiring an additional 172,706 shares during the period. Victory Capital Management Inc. owned 0.09% of Oscar Health worth $3,105,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the stock. KBC Group NV boosted its holdings in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after acquiring an additional 2,555 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in shares of Oscar Health in the 4th quarter worth about $100,000. Alberta Investment Management Corp acquired a new position in shares of Oscar Health in the 4th quarter valued at about $138,000. SMART Wealth LLC purchased a new stake in shares of Oscar Health during the 4th quarter worth about $180,000. Finally, Tempus Wealth Planning LLC purchased a new stake in shares of Oscar Health during the 4th quarter worth about $181,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Oscar Health Stock Up 0.5 %
NYSE:OSCR traded up $0.06 on Thursday, reaching $12.91. The stock had a trading volume of 2,118,833 shares, compared to its average volume of 3,635,419. The company has a 50-day moving average of $15.11 and a 200 day moving average of $16.28. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.24 billion, a P/E ratio of -645.13 and a beta of 1.75. Oscar Health, Inc. has a 12-month low of $12.43 and a 12-month high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on OSCR. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target on the stock. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of "Hold" and an average price target of $20.19.
Check Out Our Latest Report on Oscar Health
Oscar Health Company Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.